Breaks Categories: News

TuesdayNov 19, 2024 3:04 pm

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Faces DOJ Scrutiny Over Chrome Browser

The U.S. Department of Justice (“DOJ”) is considering asking Alphabet (NASDAQ: GOOGL, GOOG), parent of Google, to sell its Chrome browser. This is part of an investigation into Google’s search monopoly. Chrome is a key part of Google’s internet services, and its potential sale could be a major development in the case. This scrutiny is part of broader efforts to address concerns over Google’s dominance in the search market. The potential sale of Chrome could serve as a bargaining chip in negotiations with the DOJ. This development highlights the increasing regulatory pressure on Google to address antitrust concerns. Despite these…

Continue Reading

TuesdayNov 19, 2024 11:10 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Technology at AHA Conference

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, today announced the results from two studies evaluating its groundbreaking vector-based technology. According to the announcement, the data add to the body of evidence for HeartBeam’s key clinical indications, specifically arrhythmia and heart attack (myocardial infarction) detection, and showcase the technology’s pivotal role in advancing patient care. The studies were presented during the American Heart Association’s annual Scientific Sessions in Chicago, Nov. 16-18, 2024. “The data presentations at AHA are a testament to HeartBeam’s dedication to building a robust…

Continue Reading

TuesdayNov 19, 2024 10:57 am

NetworkNewsBreaks – Quantum Computing Inc. (NASDAQ: QUBT) Announces $40M Registered Direct Offering

Quantum (NASDAQ: QUBT) ("QCi"), an innovative, integrated photonics and quantum optics technology company, recently announced its entry into a securities purchase agreement for the purchase and sale of 16,000,000 shares of common stock, each at a purchase price of $2.50, priced at-the-market under Nasdaq rules, pursuant to a registered direct offering. Of the expected gross proceeds to QCI of $40 million, the company intends to use the net for the repayment of debt, working capital and general corporate purposes. Titan Partners Group, a division of American Capital Partners is acting as the sole placement agent for the offering. To view…

Continue Reading

TuesdayNov 19, 2024 10:28 am

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Subsidiary Partners with Bear Robotics to Revolutionize U.S. Hospitality with AI-Powered Solutions

Nightfood Holdings (OTCQB: NGTF) subsidiary Future Hospitality Ventures Holdings Inc. (“FHV”), has announced an exclusive partnership with Bear Robotics Inc. to implement AI-driven service robots in the U.S. hospitality sector, starting in Greater Los Angeles with plans for nationwide expansion. FHV aims to address industry challenges like labor shortages and rising operational costs by introducing Bear Robotics' flagship "Servi" robots, which enhance efficiency and guest experiences in hotels, restaurants, and event spaces. This collaboration positions FHV to capture growth in the expanding hospitality robotics market, projected to exceed $3 billion by 2027, while inviting investors to participate in its transformative journey.…

Continue Reading

TuesdayNov 19, 2024 9:50 am

NetworkNewsBreaks – MJBizCon Partners with Voice of the Plant to Showcase Cannabis Genetics at “The Vault” Pavilion

Cannabis industry leader MJBizCon is putting genetics center stage at its December 2024 Las Vegas convention through a new partnership with Voice of the Plant. The collaboration will feature "The Vault" Pavilion, bringing together renowned breeders and cannabis genetics companies from around the world. Led by Mario Guzman, creator of the popular Gelato and Sunset Sherbert strains, and Victorine Deych of terpene company Dusted, the pavilion will host industry veterans including Amsterdam's Sensi Seeds, Barneys Farm, and leading U.S. genetics companies. The initiative aims to refocus attention on cannabis genetics as the foundation of the industry. "Sometimes in the excitement…

Continue Reading

TuesdayNov 19, 2024 9:20 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Raises $7.5 Million Through Public Stock Offering

Calidi Biotherapeutics (NYSE American: CLDI) announced the successful closing of a public offering of 4,437,869 shares of common stock at $1.69 per share, raising approximately $7.5 million in gross proceeds. Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent for the offering, which was conducted under an effective registration statement on Form S-3 filed with the SEC. The final prospectus is available on the SEC’s website or through Ladenburg Thalmann. The offering complies with all relevant securities laws and regulations. To view the full press release, visit: https://nnw.fm/V4QJd About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that…

Continue Reading

MondayNov 18, 2024 1:44 pm

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Ownership Led by Individual Investors Holding Majority Stake

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) was featured in a recent article by Simply Wall St. The publication describes Platinum’s ownership structure, explaining that the company is primarily owned by individual investors, who hold a 51% majority stake, granting them substantial influence over the company’s governance and management decisions. Institutional investors also hold a significant portion, contributing to PTM's credibility within the investment community, though ownership remains fragmented, with the top 25 shareholders collectively owning 48%. The largest single shareholder is Hosken Consolidated Investments Limited, holding 26% of shares. Insider ownership is minimal, with less than 1%…

Continue Reading

MondayNov 18, 2024 12:50 pm

NetworkNewsBreaks – Sprout Social Inc. (NASDAQ: SPT): A Leader in Social Media Management Recognized by TrustRadius

Sprout Social (NASDAQ: SPT) is a prominent player in the social media management industry. The company offers tools that help businesses manage their social media presence effectively. Recently, Sprout Social received the 2025 Buyer’s Choice Award from TrustRadius, a testament to its strong product capabilities and customer relationships. This award is based on unbiased customer reviews collected over several months in 2024. The recognition from TrustRadius highlights Sprout Social’s commitment to providing comprehensive solutions. Customers have particularly praised the platform’s reporting features, which enhance social media strategies and engagement with senior leadership. This capability allows businesses to compare year-over-year performance,…

Continue Reading

MondayNov 18, 2024 11:50 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting

CNS Pharmaceuticals (NASDAQ: CNSP) announced that its abstract on the pivotal trial of Berubicin, a novel treatment for glioblastoma multiforme (“GBM”), has been selected for poster presentation at the 29th Annual Meeting of the Society for Neuro-Oncology. The presentation, led by Chief Medical Officer Dr. Sandra Silberman, will provide updates on the randomized, controlled CNS-201 trial comparing Berubicin to Lomustine after first-line GBM therapy. The session will take place on Nov. 22, 2024, at the George R. Brown Convention Center in Houston, TX, during the Poster and Networking Session. To view the full press release, visit https://nnw.fm/PNNKK About CNS Pharmaceuticals…

Continue Reading

MondayNov 18, 2024 11:25 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Showcases RTNova Virotherapy Breakthrough for Metastatic Cancer Treatment

Calidi Biotherapeutics (NYSE American: CLDI) presented data at the International Oncolytic Virotherapy Conference and the Society for Immunotherapy of Cancer Annual Meeting highlighting its RTNova™ systemic virotherapy technology. This innovative platform leverages a tumor-selective vaccinia virus enhanced with extracellular enveloped viruses (“EEVs”) to overcome challenges like immune clearance and limited targeting in systemic virotherapy. RTNova demonstrated potential to target and kill metastatic tumor sites across multiple oncology indications, including metastatic lung cancer, while transforming tumor microenvironments and delivering therapeutic payloads. These findings position RTNova as a groundbreaking approach for addressing advanced metastatic diseases, supporting Calidi’s mission to develop multi-modal, off-the-shelf…

Continue Reading